vs

Side-by-side financial comparison of ARGENX SE (ARGX) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.

ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.3B, roughly 1.9× OPEN TEXT CORP). ARGENX SE runs the higher net margin — 35.5% vs 12.7%, a 22.8% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -0.6%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $279.4M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Open Text Corporation is a global software company that develops and sells information management software.

ARGX vs OTEX — Head-to-Head

Bigger by revenue
ARGX
ARGX
1.9× larger
ARGX
$2.5B
$1.3B
OTEX
Growing faster (revenue YoY)
ARGX
ARGX
+83.8% gap
ARGX
83.2%
-0.6%
OTEX
Higher net margin
ARGX
ARGX
22.8% more per $
ARGX
35.5%
12.7%
OTEX
More free cash flow
ARGX
ARGX
$42.9M more FCF
ARGX
$322.4M
$279.4M
OTEX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ARGX
ARGX
OTEX
OTEX
Revenue
$2.5B
$1.3B
Net Profit
$877.2M
$168.1M
Gross Margin
89.5%
74.0%
Operating Margin
28.9%
22.0%
Net Margin
35.5%
12.7%
Revenue YoY
83.2%
-0.6%
Net Profit YoY
1.3%
-26.9%
EPS (diluted)
$13.25
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
OTEX
OTEX
Q4 25
$2.5B
$1.3B
Q3 25
$1.3B
Q2 25
$1.8B
$1.3B
Q1 25
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.3B
Q2 24
$901.9M
$1.4B
Q1 24
$1.4B
Net Profit
ARGX
ARGX
OTEX
OTEX
Q4 25
$877.2M
$168.1M
Q3 25
$146.6M
Q2 25
$414.8M
$28.8M
Q1 25
$92.8M
Q4 24
$865.6M
$229.9M
Q3 24
$84.4M
Q2 24
$-32.5M
$248.2M
Q1 24
$98.3M
Gross Margin
ARGX
ARGX
OTEX
OTEX
Q4 25
89.5%
74.0%
Q3 25
72.8%
Q2 25
89.2%
72.3%
Q1 25
71.6%
Q4 24
90.2%
73.3%
Q3 24
71.7%
Q2 24
89.4%
72.5%
Q1 24
73.0%
Operating Margin
ARGX
ARGX
OTEX
OTEX
Q4 25
28.9%
22.0%
Q3 25
21.0%
Q2 25
19.2%
13.9%
Q1 25
16.7%
Q4 24
8.7%
22.2%
Q3 24
16.3%
Q2 24
-15.4%
14.2%
Q1 24
15.7%
Net Margin
ARGX
ARGX
OTEX
OTEX
Q4 25
35.5%
12.7%
Q3 25
11.4%
Q2 25
23.4%
2.2%
Q1 25
7.4%
Q4 24
64.1%
17.2%
Q3 24
6.6%
Q2 24
-3.6%
18.2%
Q1 24
6.8%
EPS (diluted)
ARGX
ARGX
OTEX
OTEX
Q4 25
$13.25
$0.66
Q3 25
$0.58
Q2 25
$6.32
$0.11
Q1 25
$0.35
Q4 24
$13.33
$0.87
Q3 24
$0.32
Q2 24
$-0.55
$0.91
Q1 24
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
OTEX
OTEX
Cash + ST InvestmentsLiquidity on hand
$3.5B
$1.3B
Total DebtLower is stronger
$6.4B
Stockholders' EquityBook value
$7.3B
$4.0B
Total Assets
$8.7B
$13.6B
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
OTEX
OTEX
Q4 25
$3.5B
$1.3B
Q3 25
$1.1B
Q2 25
$2.1B
$1.2B
Q1 25
$1.3B
Q4 24
$1.5B
$1.1B
Q3 24
$1.0B
Q2 24
$1.4B
$1.3B
Q1 24
$1.1B
Total Debt
ARGX
ARGX
OTEX
OTEX
Q4 25
$6.4B
Q3 25
$6.4B
Q2 25
$6.4B
Q1 25
$6.4B
Q4 24
$6.4B
Q3 24
$6.4B
Q2 24
$11.0M
$6.4B
Q1 24
$8.4B
Stockholders' Equity
ARGX
ARGX
OTEX
OTEX
Q4 25
$7.3B
$4.0B
Q3 25
$4.0B
Q2 25
$6.1B
$3.9B
Q1 25
$4.1B
Q4 24
$5.5B
$4.2B
Q3 24
$4.1B
Q2 24
$4.3B
$4.2B
Q1 24
$4.1B
Total Assets
ARGX
ARGX
OTEX
OTEX
Q4 25
$8.7B
$13.6B
Q3 25
$13.5B
Q2 25
$7.2B
$13.8B
Q1 25
$13.8B
Q4 24
$6.2B
$13.7B
Q3 24
$13.8B
Q2 24
$4.8B
$14.2B
Q1 24
$16.4B
Debt / Equity
ARGX
ARGX
OTEX
OTEX
Q4 25
1.58×
Q3 25
1.61×
Q2 25
1.62×
Q1 25
1.55×
Q4 24
1.51×
Q3 24
1.55×
Q2 24
0.00×
1.52×
Q1 24
2.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
OTEX
OTEX
Operating Cash FlowLast quarter
$323.3M
$318.7M
Free Cash FlowOCF − Capex
$322.4M
$279.4M
FCF MarginFCF / Revenue
13.0%
21.1%
Capex IntensityCapex / Revenue
0.0%
3.0%
Cash ConversionOCF / Net Profit
0.37×
1.90×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$878.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
OTEX
OTEX
Q4 25
$323.3M
$318.7M
Q3 25
$147.8M
Q2 25
$361.8M
$158.2M
Q1 25
$402.2M
Q4 24
$41.9M
$348.0M
Q3 24
$-77.8M
Q2 24
$-124.7M
$185.2M
Q1 24
$384.7M
Free Cash Flow
ARGX
ARGX
OTEX
OTEX
Q4 25
$322.4M
$279.4M
Q3 25
$101.2M
Q2 25
$356.6M
$124.0M
Q1 25
$373.8M
Q4 24
$40.9M
$306.7M
Q3 24
$-117.1M
Q2 24
$-125.5M
$145.2M
Q1 24
$348.2M
FCF Margin
ARGX
ARGX
OTEX
OTEX
Q4 25
13.0%
21.1%
Q3 25
7.9%
Q2 25
20.1%
9.5%
Q1 25
29.8%
Q4 24
3.0%
23.0%
Q3 24
-9.2%
Q2 24
-13.9%
10.7%
Q1 24
24.1%
Capex Intensity
ARGX
ARGX
OTEX
OTEX
Q4 25
0.0%
3.0%
Q3 25
3.6%
Q2 25
0.3%
2.6%
Q1 25
2.3%
Q4 24
0.1%
3.1%
Q3 24
3.1%
Q2 24
0.1%
2.9%
Q1 24
2.5%
Cash Conversion
ARGX
ARGX
OTEX
OTEX
Q4 25
0.37×
1.90×
Q3 25
1.01×
Q2 25
0.87×
5.49×
Q1 25
4.33×
Q4 24
0.05×
1.51×
Q3 24
-0.92×
Q2 24
0.75×
Q1 24
3.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

OTEX
OTEX

Transferred At Point In Time$184.2M14%
Cybersecurity Enterprise Product$174.5M13%
Business Network Product$159.8M12%
Business Network Cloud Services And Subscriptions$151.4M11%
Content Cloud Services And Subscriptions$137.9M10%
Cybersecurity SMB Consumer Product$127.6M10%
Application Delivery Management Product$120.1M9%
IT Operations Management Product$113.3M9%
Professional Service And Other$82.5M6%
Analytics Product$58.1M4%
IT Operations Management Cloud Services And Subscriptions$7.8M1%

Related Comparisons